Business Development Support Sample Clauses

Business Development Support. During the Transition Period, Genaissance shall provide Sciona or its United States’ Affiliate with the following business development and technical support services: (a) one full time project manager (the identity of which manager shall be reasonably acceptable to Sciona and Genaissance and who shall be an employee of Genaissance); (b) [**] percent ([**]%) of the costs of a senior business development manager (which manager shall initially be Xxxxxxx Xxxxxx and thereafter, such person shall be reasonably acceptable to Sciona and Genaissance and who shall be a consultant hired for such purpose or otherwise an employee of Genaissance), (c) access to senior Genaissance scientists, including the [**] to support Sciona’s business development activities as reasonably required by Sciona but not to exceed [**] percent ([**]%) of a full-time equivalent unless otherwise agreed to by Genaissance, (d) [**] percent ([**]%) of the Third Party search fee to identify and recruit a Chief Executive Officer for Sciona, and (e) use of other facilities and members of Genaissance’s [**] teams from time-to-time as reasonably required by Sciona to carry out the operations contemplated by this Agreement. Such services shall be subject to such reasonable limitations as the Parties shall negotiate in good faith upon the reasonable request of Genaissance.
Sample 1Sample 2
AutoNDA by SimpleDocs
Business Development Support. SHDI will support UBI in good faith in the establishment of an agreement with another partner, [***]. Such support will include, but is not limited to, [***]. [***]. [***].
Sample 1
Business Development Support. Service Provider shall allow Customer to utilize one or more business development support programs listed in Exhibit A with respect any Products to the extent the aggregate point value of such Product/program combinations so utilized by Customer do not exceed [***] points in any calendar year. The foregoing point value allowed to Customer per calendar year shall automatically be reduced on a pro-rata basis for any year in which this Agreement is in effect for less than the full calendar year.
Sample 1
Business Development Support. Commencing January 1, 2008, Service Supplier will allow Customer to utilize one or more business development support programs listed in Schedule B with respect any Products to the extent the aggregate point value of such Product/program combinations so utilized by Customer do not exceed three (3) points in any calendar year. During the period commencing August 1, 2007 and running through December 31, 2007, Service Supplier will allow Customer to utilize one or more business development support programs listed in Schedule B with respect any Products to the extent the aggregate point value of such Product/program combinations so utilized by Customer do not exceed two (2) points.
Sample 1
Business Development Support. Medallion shall provide business development support to Bank as requested. Such support shall include, but shall not be limited to, identifying new business opportunities and potential acquisitions for Bank (each a “Target”) to enable Bank to further diversify its business, advising and assisting Bank in discussions with each Target, advising Bank on the desirability of consummating a transaction with each Target and in arriving at definitive financial terms with respect to any particular acquisition and conducting due diligence of each Target with the objective of developing a full understanding of the business and characteristics of each Target.”
Sample 1

Related to Business Development Support

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Business Development Company Status The Company, during a period of at least 12 months from the Closing Time, will use its commercially reasonable efforts to maintain its status as a business development company; provided, however, the Company may cease to be, or withdraw its election as, a business development company, with the approval of the board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Status as Business Development Company The Borrower is an “investment company” that has elected to be regulated as a “business development company” within the meaning of the Investment Company Act and qualifies as a RIC.

  • TECHNICAL SUPPORT SERVICES 2.1 The technical support services (the "Services"): Party A agrees to provide to Party B the relevant services requested by Party B, which are specified in Exhibit 1 attached hereto ("Exhibit 1").

  • Technology Transfer Subject to the terms of the Development Supply Agreement, as soon as reasonably practicable, but in no event later than the fifth (5th) anniversary of the Effective Date, Alnylam shall initiate a technology transfer to MedCo, or to its Third Party manufacturer(s) of Licensed Product, selected by MedCo and reasonably acceptable to Alnylam, of Alnylam Know-How that is reasonably necessary or useful for the Manufacture of the Licensed Product, and shall make available its personnel on a reasonable basis to consult with MedCo or such Third Party manufacturer(s) with respect thereto, all at MedCo’s expense, including the Costs reasonably incurred by Alnylam in connection with such technology transfer activities. MedCo shall reimburse Alnylam such Costs incurred with respect to such Manufacturing technology transfer within [***] days after receipt of an invoice therefor. Alnylam and its Affiliates shall keep complete and accurate records in sufficient detail to enable the payments payable hereunder to be determined. Alnylam shall not be required to perform technology transfer to more than one Third Party manufacturer for each stage of the Licensed Product supply chain (i.e., Bulk Drug Substance, Bulk Drug Product and Finished Product). Promptly after MedCo’s written request, Alnylam shall use Commercially Reasonable Efforts to assign to MedCo any manufacturing agreement between Alnylam and a Third Party that is solely related to the manufacture of Licensed Products. Such assignment shall be subject to the terms and conditions of such agreement, including any required consents of such Third Party and MedCo’s written agreement to assume all the obligations of Alnylam under such agreement to be undertaken after such assignment, but Alnylam shall remain solely responsible for its obligations under such agreement arising prior to such assignment. Except as provided in the immediately preceding sentence, MedCo shall be solely responsible for contracting with such Third Party manufacturer (and any other Third Party manufacture to whom Alnylam has initiated technology transfer as set forth in this Section 5.3) for the supply of such Licensed Product and Alnylam shall have no obligations under such agreement between MedCo and such Third Party manufacturer. Alnylam shall use Commercially Reasonable Efforts to obtain any such consent in a form reasonably acceptable to MedCo.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

Time is Money Join Law Insider Premium to draft better contracts faster.